bf/NASDAQ:GALT_icon.jpeg

COM:GALECTINTHERAPEUTICS

Galectin Therapeutics

  • Stock

USD

Last Close

2.72

22/11 21:00

Market Cap

145.43M

Beta: -

Volume Today

132.79K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
average payables
579.50K
-
834K
43.92%
677K
18.82%
679K
0.30%
759K
11.78%
452.50K
40.38%
979K
116.35%
1.48M
50.82%
1.55M
4.88%
2.85M
83.89%
5.16M
81.23%
average receivables
book value per share
0.49
-
0.97
98.97%
1.04
7.05%
0.41
60.40%
0.03
91.83%
0.18
421.10%
0.87
398.72%
0.52
40.53%
0.02
97.06%
-0.57
3,842.84%
-1.00
75.35%
capex per share
-0.00
-
capex to depreciation
-0.42
-
capex to operating cash flow
0.00
-
capex to revenue
cash per share
0.62
-
1.33
114.47%
1.07
19.62%
0.53
50.93%
0.09
83.65%
0.21
143.62%
0.91
334.07%
0.48
47.64%
0.68
42.34%
0.31
53.79%
0.43
36.25%
days of inventory on hand
days payables outstanding
71.13K
-
days sales outstanding
debt to assets
0.00
-
0.00
84.73%
0.69
46,632.41%
1.87
169.63%
2.55
35.91%
debt to equity
0.00
-
0.00
73.79%
32.54
2,188,787.31%
-1.18
103.61%
-1.19
1.38%
dividend yield
0.01
-
0.01
73.75%
0.02
91.66%
0.03
8.58%
0.01
59.88%
0.01
34.82%
0.00
61.04%
0.00
59.33%
0.00
31.61%
0.00
2.40%
0.00
16.86%
earnings yield
-0.09
-
-0.21
134.88%
-0.51
143.12%
-0.75
47.91%
-0.14
81.73%
-0.10
24.86%
-0.09
12.89%
-0.18
105.53%
-0.26
38.89%
-0.58
128.46%
-0.41
29.60%
enterprise value
125.85M
-
46.69M
62.90%
13.71M
70.63%
13.26M
3.26%
115.59M
771.45%
126.94M
9.82%
101.96M
19.68%
100.65M
1.29%
110.56M
9.85%
88.39M
20.05%
146.01M
65.19%
enterprise value over ebitda
-10.42
-
-3.03
70.97%
-0.68
77.42%
-0.62
9.58%
-7.13
1,053.58%
-9.36
31.34%
-7.74
17.29%
-4.31
44.38%
-3.66
14.90%
-2.31
37.01%
-3.84
66.33%
ev to operating cash flow
-16.82
-
-3.76
77.66%
-0.81
78.51%
-0.81
0.12%
-7.27
799.80%
-12.47
71.46%
-9.40
24.63%
-4.89
48.02%
-4.55
6.90%
-2.85
37.42%
-4.43
55.63%
ev to sales
free cash flow per share
-0.44
-
-0.57
28.14%
-0.70
23.80%
-0.56
20.23%
-0.45
20.34%
-0.26
42.28%
-0.21
19.59%
-0.36
73.95%
-0.42
14.97%
-0.52
25.90%
-0.55
4.79%
free cash flow yield
-0.05
-
-0.16
198.38%
-0.43
161.95%
-0.57
33.52%
-0.13
76.63%
-0.08
43.79%
-0.07
3.56%
-0.16
122.10%
-0.20
24.42%
-0.46
130.63%
-0.33
28.67%
graham net net
0.47
-
0.94
99.24%
1.02
7.43%
0.40
60.95%
0.00
99.40%
0.16
6,415.35%
0.85
447.72%
0.38
55.37%
-0.02
105.77%
-0.62
2,705.40%
-1.04
69.30%
graham number
2.80
-
3.97
41.67%
4.40
10.91%
2.61
40.84%
0.59
77.44%
1.18
100.52%
2.24
90.33%
2.19
2.16%
0.43
80.58%
2.91
583.21%
3.92
34.67%
income quality
0.62
-
0.79
27.12%
0.85
7.74%
0.77
9.73%
0.98
27.88%
0.73
25.19%
0.82
11.43%
0.88
7.59%
0.80
9.30%
0.80
0.58%
0.80
0.23%
intangibles to total assets
0.00
-
0.00
76.46%
0.00
40.06%
0.00
79.10%
0
100%
0
0
0
0
0
0
interest coverage
-1.35K
-
-40.48
97.01%
-154.46
281.55%
-269.47
74.46%
-61.72
77.10%
-37.13
39.84%
13.64
136.73%
interest debt per share
0.00
-
0.01
2,423.44%
0.00
71.71%
0.00
4.77%
0.50
21,876.18%
0.69
36.42%
1.15
66.53%
inventory turnover
invested capital
0.00
-
0.00
73.79%
32.54
2,188,787.31%
-1.18
103.61%
-1.19
1.38%
market cap
136.34M
-
75.82M
44.39%
39.56M
47.83%
28.63M
27.63%
118.64M
314.45%
135.19M
13.95%
149.40M
10.51%
127.74M
14.50%
121.15M
5.16%
67.11M
44.60%
99.86M
48.80%
net current asset value
8.20M
-
21.18M
158.25%
25.04M
18.23%
12.01M
52.02%
851K
92.92%
6.72M
690.13%
45.34M
574.26%
24.06M
46.94%
886K
96.32%
-34.65M
4,010.84%
-60.73M
75.27%
net debt to ebitda
0.87
-
1.89
117.34%
1.29
31.79%
0.72
44.44%
0.19
73.69%
0.61
223.30%
3.60
491.94%
1.16
67.82%
0.35
69.72%
-0.56
258.26%
-1.21
118.39%
net income per share
-0.72
-
-0.72
0.87%
-0.83
14.91%
-0.73
11.63%
-0.46
37.71%
-0.35
22.84%
-0.26
27.37%
-0.41
60.98%
-0.53
28.35%
-0.66
24.71%
-0.68
3.42%
operating cash flow per share
-0.44
-
-0.57
28.23%
-0.70
23.80%
-0.56
20.23%
-0.45
20.34%
-0.26
42.28%
-0.21
19.59%
-0.36
73.95%
-0.42
14.97%
-0.52
25.90%
-0.55
4.79%
payables turnover
0.01
-
receivables turnover
research and ddevelopement to revenue
return on tangible assets
-1.13
-
-0.53
52.93%
-0.76
42.52%
-1.36
78.91%
-3.90
187.48%
-1.54
60.44%
-0.28
82.11%
-0.79
187.76%
-0.74
6.79%
-1.84
148.69%
-1.46
20.93%
revenue per share
roe
-1.47
-
-0.74
49.30%
-0.80
7.34%
-1.78
123.14%
-13.61
662.77%
-2.02
85.19%
-0.29
85.44%
-0.79
170.71%
-34.69
4,266.04%
1.16
103.33%
0.68
41.02%
roic
-1.47
-
-0.73
50.75%
-0.80
10.48%
-1.79
123.03%
-13.64
662.86%
-1.97
85.54%
-0.30
84.98%
-0.79
167.23%
-1.02
29.16%
-6.47
533.11%
-3.29
49.14%
sales general and administrative to revenue
shareholders equity per share
0.49
-
0.97
98.97%
1.04
7.05%
0.41
60.40%
0.03
91.83%
0.18
421.10%
0.87
398.72%
0.52
40.53%
0.02
97.06%
-0.57
3,842.84%
-1.00
75.35%
stock based compensation to revenue
tangible asset value
8.20M
-
21.18M
158.17%
25.04M
18.22%
12.01M
52.02%
1.19M
90.07%
6.90M
478.21%
45.59M
560.99%
24.19M
46.94%
893K
96.31%
-33.92M
3,898.10%
-60.24M
77.61%
tangible book value per share
0.49
-
0.97
99.38%
1.04
7.09%
0.41
60.39%
0.03
91.83%
0.18
421.10%
0.87
398.72%
0.42
51.40%
0.02
96.40%
-0.57
3,842.84%
-1.00
75.35%
working capital
8.20M
-
27.96M
240.91%
25.04M
10.44%
12.01M
52.02%
851K
92.92%
6.72M
690.13%
45.39M
575.03%
24.07M
46.98%
32.79M
36.24%
7.54M
77.00%
12.03M
59.60%

All numbers in USD (except ratios and percentages)